JILL WOODRING: Open Payments
NPI 1588025969 · ROY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 27 payments from 15 companies in 2025. Trend: 2023 $646 · 2024 $1,039 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $126 |
| Axsome Therapeutics, Inc. | 4 | $78 |
| PFIZER INC. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Abbott Laboratories | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: Auvelity, NURTEC ODT, VRAYLAR, UBRELVY, CAPLYTA, QULIPTA, GEMTESA, FREESTYLE LIBRE 3.
Industry payments across UT — which companies pay providers there.
